Search

Find exactly what you’re looking for.
Search

Showing 161-179 of 179 results

EXPLORING THE REGULATION, LITIGATION AND ENFORCEMENT OF MARIJUANA Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, will speak at ACI’s Controlled Substances – Regulation, Litigation, and Enforcement Summit in Washington, DC on July 12th as a panelist during the session on “Exploring...

Cannabis Law Partner Zachary Kobrin published an article for the Cannabis Industry Journal on how the cannabis industry can benefit from the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act which was recently introduced in Congress. The Act creates greater access to capital...

Midyear Cannabis Update: 4 Industry Trends to Watch Saul Ewing’s Jonathan Havens shares the biggest developments he’s seen so far in 2022, as well as which trends industry stakeholders should watch during the second half of the year.

​A new City of Chicago Ordinance requires that condominium associations and other highrise residential buildings provide relief for residents during extreme heat events. On June 22, 2022, in response to the heat-related deaths of residents of a senior living facility, the Chicago City Council...

FDA Bans JUUL Products From US Market Cannabis industry stakeholders weigh in on what the decision could mean for businesses in the cannabis space. By Melissa Schiller On the other hand, Jonathan Havens, co-chair of Saul Ewing’s Cannabis Law Practice and chair of the firm’s Food, Beverage and...

FDA takes another look at CBD, but insiders are skeptical much will change U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements. But hopes are dim that Tuesday’s daylong review by the U.S. Food and Drug...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice and Food, Beverage and Agribusiness Practice, will speak at the Food and Drug Law Institute’s Annual Conference as a panelist during the session on “Preparing for Federal Legalization of Cannabis: Lessons Learned from Other Industries.”...

On June 8, 2022, David Sugar, chair of the Firm's Condominium and Community Association Practice, gave a presentation on “Challenges and Opportunities for Condominium Board Members” to Chicago Loop Neighbors, an organization whose members are the presidents of most the large condominium associations...

Zachary Kobrin spoke on a panel titled, “A comparison of State Models” at the 6th Annual Canna Business & Wellness Conference and Expo, presented by the Cannabis Law, Accounting & Business (Cannabis LAB). The conference focused on the critical issues and challenges impacting the entire industry.

Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...

Cannabis Law Partner Zachary Kobrin was featured in a CTFN article discussing the New York State Attorney General’s investigation into the Columbia Care/Cresco Labs merger. While the move by state authorities represents one of the first antitrust investigations of its kind into the cannabis industry...

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act. By Melissa Schiller Jonathan Havens, co-chair of the Cannabis...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, and co-chair of the Firm's Food, Beverage and Agribusiness Practice, spoke at the Food and Drug Law Institute's 2022 Legal and Practical Issues in Cannabis Regulation Conference on May 25, 2022. Jonathan's topic was "Facilitating...

FACILITATING STAKEHOLDER COLLABORATION TO IMPROVE FUTURE CANNABIS REGULATION Jonathan Havens, Co-Chair of the Firm's Cannabis Law Practice, and Co-Chair of the Firm's Food, Beverage and Agribusiness Practice, will be speaking at the Food and Drug Law Institute's 2022 Legal and Practical Issues in...

AstraZeneca’s ambitious vaccine dreams are finally, officially dead One major caveat: even if the bill passes, it would be up to the FDA to decide when to crack down — and not everyone is convinced they will. “I’m, for one, a bit skeptical that this would immediately change [things] too much, unless...

Saul Ewing’s Condominium and Community Associations Practice is pleased to once again offer its annual summary of the Illinois Condominium Property Act ("ICPA"). 2020 and 2021 were years that no one will soon forget, with condominium associations scrambling to ensure resident safety in the midst of...

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp. , lead underwriter of an overnight marketed...

For More Information
Contact us